neflamapimod
Phase 2Active 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Dementia With Lewy Bodies (DLB)
Conditions
Dementia With Lewy Bodies (DLB)
Trial Timeline
Oct 16, 2024 → Apr 1, 2026
NCT ID
NCT06815965About neflamapimod
neflamapimod is a phase 2 stage product being developed by CervoMed for Dementia With Lewy Bodies (DLB). The current trial status is active. This product is registered under clinical trial identifier NCT06815965. Target conditions include Dementia With Lewy Bodies (DLB).
What happened to similar drugs?
6 of 20 similar drugs in Dementia With Lewy Bodies (DLB) were approved
Approved (6) Terminated (1) Active (13)
Hype Score Breakdown
Clinical
12
Activity
12
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06815965 | Phase 2 | Active |
Competing Products
20 competing products in Dementia With Lewy Bodies (DLB)
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| [18F]NAV4694 | Navidea Biopharmaceuticals | Phase 3 | 26 |
| AL001 + Placebo + Open label - AL001 | Alector | Phase 3 | 22 |
| AL001 | Alector | Phase 2 | 25 |
| ATH-1017 + Placebo | LeonaBio | Phase 2 | 17 |
| IGC AD1 + Placebo | IGC Pharma | Phase 1 | 19 |
| E2020 + Placebo | Eisai | Approved | 43 |
| ARICEPT | Eisai | Phase 3 | 40 |
| Rasagiline | Eisai | Phase 2 | 35 |
| Donepezil Hydrochloride | Eisai | Pre-clinical | 26 |
| donepezil hcl | Eisai | Phase 3 | 40 |
| Donepezil 5 mg + Donepezil 10 mg + Donepezil matched placebo | Eisai | Phase 3 | 40 |
| E2020 + E2020 | Eisai | Phase 2 | 35 |
| donepezil hydrochloride (Aricept) | Eisai | Approved | 43 |
| 3 mg Donepezil hydrochloride + 5 mg Donepezil hydrochloride + 10 mg Donepezil hydrochloride + Placebo | Eisai | Phase 2 | 35 |
| E2020 + E2020 | Eisai | Phase 3 | 40 |
| Irsenontrine + Placebo | Eisai | Phase 2 | 35 |
| E2020 | Eisai | Phase 2 | 35 |
| Mecobalamin | Eisai | Approved | 43 |
| E2020 + Placebo | Eisai | Phase 3 | 40 |
| Donepezil Hydrochloride | Eisai | Phase 3 | 40 |